Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland

Clinical Microbiology and Infection

Volumn 10, Issue 7, 2004, Pages 657-659

  Clarke, P ^a   Murchan, S ^b   Smyth, E G ^a,b   Humphreys, H ^a,b  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

Antimicrobial susceptibility; Penicillin; Resistance; Streptococcus pneumoniae

Indexed keywords

CEFOTAXIME; CIPROFLOXACIN; ERYTHROMYCIN; LINEZOLID; MOXIFLOXACIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; HUMAN; IRELAND; MINIMUM INHIBITORY CONCENTRATION; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 4043100420     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2004.00894.x     Document Type: Article

References (15)

1. McKenzie H, Reid N, Dijkhuizen RS. Clinical and micro-biological epidemiology of Streptococcus pneumoniae bacteraemia. J Med Microbiol 2000; 49: 361-366.
2. Johnson AP, Speller DCE, George RC, Warner M, Domingue G, Efstratiou A. Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995. BMJ 1996; 312: 1454-1456.
3. Jetté LP, Delage G, Ringuette L et al. Surveillance of invasive Streptococcus pneumoniae infection in the province of Quebec, Canada, from 1996 to 1998: serotype distribution, antimicrobial susceptibility, and clinical characteristics. J Clin Microbiol 2001; 39: 733-737.
4. Fiore AE, Moroney JF, Farley MM et al. Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clin Infect Dis 2000; 30: 71-77.
5. British Society for Antimicrobial Chemotherapy Working Party. Antimicrobial susceptibility testing. J Antimicrob Chemother 2001; 48(suppl S1): 1-102.
6. European Antimicrobial Resistance Surveillance System. Proportion of PNSP isolates in participating centres in EARSS. http://www.earss.rivm.nl/PAGINA/interwebsite/home_earss.html
7. Bronzwaer SLAM, Cars O, Bucholz U et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002; 8: 278-282.
8. Reinert RR, Al-Lahham AA, Lemperle M et al. Emergence of macrolide and penicillin resistance amongst invasive pneumococcal isolates in Germany. J Antimicrob Chemother 2002; 49: 61-68.
9. Felmingham D, Tesfaslasie Y, Burley C, Masterton RG. Penicillin resistance in pneumococci. J Antimicrob Chemother 2000; 45: 710-711.
10. Sahm DF, Peterson DE, Critchley IA, Thornsberry C. Analysis of ciprofloxacin activity against Streptococcus pneumoniae after 10 years of use in the United States. Antimicrob Agents Chemother 2000; 44: 2521-2524.
11. Johnson AP, Warner M, George RC, Livermore DM. Activity of moxifloxacin against clinical isolates of Streptococcus pneumoniae from England and Wales. J Antimicrob Chemother 2001; 47: 411-415.
12. Hooper DC. Fluoroquinolone resistance amongst Gram-positive cocci. Lancet Infect Dis 2002; 2: 530-538.
13. Diekema DJ, Jones RJ. Oxazolidinone antibiotics. Lancet 2001; 358: 1975-1982.
14. Johnson AP, Warner M, Livermore DM. Activity of linezolid against multi-resistant Gram-positive bacteria from diverse hospitals in the United Kingdom. J Antimicrob Chemother 2000; 45: 225-230.
15. Bennett D, Lennon B, Humphreys H, Cafferkey M. Penicillin susceptibility and epidemiological typing of invasive pneumococcal isolates in the Republic of Ireland. J Clin Microbiol 2003; 41: 3641-3648.